Pushing risky drugs
Even as expert advisers to the Food and Drug Administration prepare to take a closer look at a potentially risky class of painkillers, the COX-2 inhibitors, disturbing new evidence has emerged that
Even as expert advisers to the Food and Drug Administration prepare to take a closer look at a potentially risky class of painkillers, the COX-2 inhibitors, disturbing new evidence has emerged that